Evidence map›Paper›PMID 27551155›Full record

ArticleThe Journal of experimental medicine2016

IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization.

Juhan Yoon, Juan Manuel Leyva-Castillo, Guoxing Wang, Claire Galand, Michiko K Oyoshi, Lalit Kumar, Sabine Hoff, Rui He, Alexander Chervonsky, Joost J Oppenheim and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. IL-4 acts on skin-derived dendritic cells to promote the TThe Journal of allergy and clinical immunology · 2024
    Article
  7. Article
  8. Basophils are important for development of allergic skin inflammation.The Journal of allergy and clinical immunology · 2024
    Article
  9. Article
  10. Article
  11. IL-23 stabilizes an effector TNature immunology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

Juhan YoonDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.
Juan Manuel Leyva-CastilloDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-7394-4457
Guoxing WangDivision of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-7762-4848
Claire GalandDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-8005-4831
Michiko K OyoshiDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.
Lalit KumarDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.ORCID 0000-0003-2045-298X
Sabine HoffDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.
Rui HeDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-5288-9786
Alexander ChervonskyDepartment of Pathology, University of Chicago, Chicago, IL 60637.
Joost J OppenheimLaboratory of Molecular Immunoregulation, National Cancer Institute, Frederick, MD 21702.
Vijay K KuchrooCenter for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-7177-2110
Marcel R M van den BrinkDepartment of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.ORCID 0000-0003-0696-4401
Rene De Waal MalefytMerck Research Laboratories, Palo Alto, CA 94304.ORCID 0000-0002-2663-383X
Philippe A TessierCentre de Recherche du Centre Hospitalier de l'Université Laval, Sainte-Foy, Quebec QC G1V 4G2, Canada.ORCID 0000-0001-7177-7763
Robert FuhlbriggeDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-0911-9310
Philip RosenstielInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, 24105 Kiel, Germany.
Cox TerhorstDivision of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-6233-7029
George MurphyDepartment of Dermatology, Harvard Medical School, Boston, MA 02115 Division of Dermatopathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-3909-1160
Raif S GehaDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115 raif.geha@childrens.harvard.edu.ORCID 0000-0002-6019-3751
Boston Children's Hospital · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USCentre hospitalier de l'Université Laval · CAChristian-Albrechts-Universität zu Kiel · DEMemorial Sloan Kettering Cancer Center · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USNational Cancer Institute · USUniversity of Chicago · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Targeted Microbiome Transplant in Atopic DermatitisU19AI117673 · NIAID · NATIONAL JEWISH HEALTH · PI GEHA, RAIF SALIM · 2015 to 2019
$30.6M
Studies of Receptor Interactions and Effects of AlarminsZIABC009369 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OPPENHEIM, JOOST J · 2009 to 2022
$16.5M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
The Next Generation Immunoanalysis CoreP30AR069625 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2016 to 2025
$8.8M
NCI NIH HHS P30 CA008748NIAID NIH HHS U01 AI147462NIAID NIH HHS U19 AI117673NIAMS NIH HHS P30 AR069625NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a Th2-dominated inflammatory skin disease characterized by epidermal thickening. Serum levels of IL-22, a cytokine known to induce keratinocyte proliferation, are elevated in AD, and Th22 cells infiltrate AD skin lesions. We show that application of antigen to mouse skin subjected to tape stripping, a surrogate for scratching, induces an IL-22 response that drives epidermal hyperplasia and keratinocyte proliferation in a mouse model of skin inflammation that shares many features of AD. DC-derived IL-23 is known to act on CD4(+) T cells to induce IL-22 production. However, the mechanisms that drive IL-23 production by skin DCs in response to cutaneous sensitization are not well understood. We demonstrate that IL-23 released by keratinocytes in response to endogenous TLR4 ligands causes skin DCs, which selectively express IL-23R, to up-regulate their endogenous IL-23 production and drive an IL-22 response in naive CD4(+) T cells that mediates epidermal thickening. We also show that IL-23 is released in human skin after scratching and polarizes human skin DCs to drive an IL-22 response, supporting the utility of IL-23 and IL-22 blockade in AD.

Indexed as

Cell PolarityImmunizationAdultAnimalsAntigensCD4-Positive T-LymphocytesCell MovementCell ProliferationDendritic CellsEpidermisFemaleHematopoiesisHumansInterleukin-22Interleukin-23InterleukinsAntigensInterleukin-22Interleukin-23InterleukinsLigandsToll-Like Receptor 4

Identifiers

PMID27551155
PMCPMC5032726
OpenAlexW2515620899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.